Through the integration of computational modeling and experimental validation, this study has not only identified VE-822 as a promising candidate for targeted therapy of CRC but has also provided deeper insights into the biological mechanisms underlying FUT8-mediated tumorigenesis. Here, FUT8 is linked to colorectal carcinoma.